Source AP ©

Hologic Inc to buy Cytyc Corp

Hologic Inc., a maker of diagnostic and medical imaging systems, will acquire medical device maker Cytyc Corp. and create a $10 billion (7.42 billion EUR) company that focuses exclusively on advanced technology in women's health.

The $6.2 billion (4.6 billion EUR) cash and stock transaction was unanimously approved by the companies' boards of directors and is expected to be completed in the third quarter of 2007, Bedford-based Hologic and Cytyc, based in nearby Marlborough, said in a joint statement.

The combination is expected to drive cross-selling across units of the new company, generating more than $75 million (55.65 million EUR) in extra revenues within the first three years. Efficiencies in marketing, purchasing, logistics and shared administrative services are expected to generate $25 million (18.55 million EUR) to $30 million (22.26 million EUR) in annual cost savings, according to the statement.

Under the terms of the deal, Cytyc shareholders will receive 0.52 share of Hologic common stock and $16.50 (12.24 EUR) in cash for each share of Cytyc common stock they own. That translates to $46.46 per share, or a premium of about 33 percent over Cytyc shares' closing price Friday of $35.05.

The combined company will be called Hologic, and Cytyc will become its wholly owned subsidiary. It will be one of the largest companies in the world that focuses exclusively on technology in women's health, including screening, diagnostics and therapeutics for breast and cervical cancers, prenatal health, osteoporosis and permanent contraception, the companies said.

"By combining our companies' complementary, best-in-class products and technologies, we expect to drive enhanced growth and value creation," Hologic Chairman and Chief Executive Officer Jack Cumming said.

"This is a great transaction that provides Cytyc shareholders with enhanced value both today and over the long-term," said Cytyc's chairman, president and CEO, Patrick Sullivan.

The deal is subject to approval by regulators and both companies' shareholders.

Comments
Ukraine dreams of what it can do to Crimea after winning war with Russia
Who loses and wins most from Caspian Sea division
Who loses and wins most from Caspian Sea division
Ukraine dreams of what it can do to Crimea after winning war with Russia
Ukraine dreams of what it can do to Crimea after winning war with Russia
Who loses and wins most from Caspian Sea division
Pilot shares his impressions after flying Su-57 fifth-generation fighter
Trump's solar wall and barefaced lies
US-Russian confrontation: War is peace, freedom is slavery
Why Russia continues investing in US public debt
Ukraine and PMC Blackwater to poison Donbass with radioactive waste
Ukraine dreams of what it can do to Crimea after winning war with Russia
Ukraine and PMC Blackwater to poison Donbass with radioactive waste
Ukraine dreams of what it can do to Crimea after winning war with Russia
Turkey desperately tries to rescue its national currency as it falls to all-time lows
Who loses and wins most from Caspian Sea division
Ukraine dreams of what it can do to Crimea after winning war with Russia
Ukraine dreams of what it can do to Crimea after winning war with Russia
Turkey desperately tries to rescue its national currency as it falls to all-time lows
Russians tired of Putin's foreign policy
Ukraine dreams of what it can do to Crimea after winning war with Russia